Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Dysentery

• Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults
• Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years
• Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years
• Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery
• A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults
• Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea
• A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.
• Auranofin for Giardia Protozoa
• Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea
• Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
• Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea
• Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
• Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)
• Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea
• Rifaximin for Prevention of Travellers' Diarrhea
• New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management- Surveillance Study for Adverse Effects
• Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea
• Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.
• Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea
• Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea